1. Zureik M, Courbon D, Ducimetiere P. Decline in serum total cholesterol and the risk of death from cancer. Epidemiology. 1997 Mar;8(2):137-43.
2. Neaton JD, Blackburn H, Jacobs D, et al. Serum cholesterol level and mortality find- ings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med. 1992 Jul;152(7):1490-500.
3. Sarchiapone M, Roy A, Camardese G, De Risio S. Further evidence for low serum cholesterol and suicidal behaviour. J Affect Disord. 2000 Dec;61(1-2):69-71.
4. Glueck CJ, Tieger M, Kunkel R, Hamer T, Tracy T, Speirs J. Hypocholesterolemia and affective disorders. Am J Med Sci. 1994 Oct;308(4):218-25.
5. Iribarren C, Reed DM, Burchfiel CM, Dwyer JH. Serum total cholesterol and mortality. Confounding factors and risk modifications in Japanese-American men. JAMA. 1995 Jun 28;273(24):1926-32.
6. Oganov RG, Sestov DB, Deev AD, et al. Increased risk of death from coronary heart disease in men with low blood con- centration of total cholesterol and low den- sity lipoprotein cholesterol according to data from a prospective epidemiologic study in Moscow and Leningrad within the framework of Soviet-American coopera- tion. Ter Arkh. 1991;63(1):6-11.
7. Corti MC, Guralnik JM, Salive ME, et al. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med. 1997 May 15;126(10):753-60.
8. Dzugan SA, Smith RA. Broad spectrum restoration in natural steroid hormones as possible treatment for hypercholes- terolemia. Bull Urg Rec Med. 2002;3:278- 84.
9. Dzugan SA, Smith RA. Hypercholesterol- emia treatment: a new hypothesis or just an accident. Med Hypotheses. 2002 Dec;59(6):751-6.
10. Shambharkar AV, Varshney VP, Agarwal N, Agarwal SK, Sanwal PC, Pande JK. Changes in serum triiodothyronine, thy- roxine, estradiol-17 beta, progesterone lev- els and egg production in hypocholes- terolemia induced Japanese quails Coturnix coturnix japonica. Indian J Exp Biol. 1996 Oct;34(10):987-90.
11. Boston PF, Dursun SM, Reveley MA. Cholesterol and mental disorder. Br J Psychiatry. 1996 Dec;169(6):682-9.
12. Heinz A, Weingartner H, George D, Hommer D, Wolkowitz OM, Linnoila M. Severity of depression in abstinent alco- holics is associated is associated with monoamine metabolites and dehy- droepiandrosterone-sulfate concentra- tions. Psychiatry Res. 1999 Dec 20;89(2):97- 106.
13. Vallee M, Mayo W, Le Moal M. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging. Brain Res Brain Res Rev. 2001 Nov;37(1-3):301-12.
14. Marcel B, Komaroff AL, Fagioli LR, Kornish RJ, Albert MS. Cognitive deficits in patients with chronic fatigue syndrome. Biol Psyciatry. 1996 Sep 15;40(6):535-41.
15. Manu P, Lane TJ, Matthews DA. Chronic fatigue and chronic fatigue syndrome: clin- ical epidemiology and aetiological classifi- cation. Ciba Found Symp. 1993;173:23-31.
16. Afari N, Buchwald D. Chronic fatigue syn- drome: a review. Am J Psychiatry. 2003 Feb;160(2):221-36.
17. Ogden CL, Carroll MD, Flegal KM. Epidemiologic trends in overweight and obesity. Endocrinol Metab Clin North Am. 2003 Dec;32(4):741-60.
18. Thom E. Hydroxycitrate (HCA) in the treatment of obesity. Int J Obes Relat Metab Disord. 1996;20(Suppl 4):75.
19. Park Y, Albright KJ, Liu W, Storkson JM, Cook ME, Pariza MW. Effect of conjugated linoleic acid on body composition in mice. Lipids. 1997 Aug;32(8):853-8.
20. Muldoon MF, Kritchevsky SB, Evans RW, Kagan VE. Serum total antioxidant activi- ty in relative hypo- and hypercholes- terolemia. Free Radic Res. 1996 Sep;25(3):239-45.
21. Abe T, Sakamoto T, Higashi T, Hirota K. Effects of exercise on hypocholesterolemia of stroke-prone spontaneously hyperten- sive rats. Atherosclerosis. 1989 Oct;79(2- 3):113-9. |